Author

Katalin Tóth

Scripps Research InstituteORCID 0000-0002-7818-0238Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Michael D. CameroniD· 3 shared Courtney A. MilleriD· 2 shared Erica J. Young· 2 shared Gavin RumbaughiD· 2 shared László RadnaiiD· 2 shared Patrick R. GriffiniD· 2 shared Theodore M. KameneckaiD· 2 shared Aagam Patel· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Michael D. CameronORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCellPeer-reviewedJun 10, 2025

MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in Glioblastoma

Rajappa S. Kenchappa, László Radnai, Erica J. Young…·Steven S. Rosenfeld

22 citationstop 2%

mouseexperimental assay

𝕏 PostBluesky

Cell BiologyCellPeer-reviewedOct 7, 2024

Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic Potential

László Radnai, Erica J. Young, Carlos Massayuki Kikuti…·Courtney A. Miller

This paper develops a selective non-muscle myosin II inhibitor, MT-228, with high brain penetration and efficacy in preclinical models, offering therapeutic potential for diseases like stimulant use disorder.

11 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky

NeuroscienceNeuropharmacologyPeer-reviewedJun 18, 2021

A Promising Chemical Series of Positive Allosteric Modulators of the μ-Opioid Receptor that Enhance the Antinociceptive Efficacy of Opioids but not their Adverse Effects

Kerri D. Pryce, Hye Jin Kang, Farhana Sakloth…·Marta Filizola

The paper characterizes two MOR PAMs that enhance opioid antinociception without increasing adverse effects in mouse models.

35 citations

mouseexperimental assay

𝕏 PostBluesky